Thomas Gildea, MD

216.444.6503

Thomas Gildea, MD
Department: Pulmonary Medicine
Location: Cleveland Clinic Main Campus
Mail Code M2-141
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6503
DeskDesk:216.444.6490
WorkFax:216.445.0474
Thomas Gildea, MD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code M2-141
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6503
WorkFax:216.445.0474
Thomas Gildea, MD
Department: Critical Care Medicine
Location: Cleveland Clinic Main Campus
Mail Code M2-141
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6503
WorkFax:216.445.0474
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Thomas Robert Gildea, MD, FCCP, was appointed to Cleveland Clinic in 2003 in the Advanced Lung Disease Section of the Department of Pulmonary Allergy and Critical Care Medicine.

He is board-certified in internal medicine, pulmonary disease and critical care medicine. As a Chief Resident in the Yale Primary Care Internal Medicine residency, he went to Russia in a faculty exchange program to lecture and demonstrate American medical team structure and the basics of clinical epidemiology.

He has advanced training in interventional and advanced diagnostic bronchoscopy, which was part of his fellowship training at Cleveland Clinic. His clinical interests span the realm of advanced lung diseases, including lung volume reduction, lung transplantation, pulmonary arterial hypertension and are most focused on advanced diagnostic and therapeutic bronchoscopy.

Dr. Gildea was the first physician in North America to perform electromagnetic navigation bronchoscopy. He was given an Innovator Award at Cleveland Clinic in 2005 with his team proposing a novel device for a bronchoscopy needle-delivered fiducial lung implant. He has been named one of the Best Doctors in America. He also received a physician development award by the AlphaOne Foundation to study lung function changes after lung transplantation. Under his co-direction, the Center for Major Airway Diseases has brought together teams from Thoracic surgery and ENT for complex airway disease management.

An invited lecturer at national and international medical meetings, Dr. Gildea is recognized expert in the field on interventional pulmonary medicine.

Professional Highlights

  • Cleveland Clinic Innovator Award, 2005

Education & Fellowships

Fellowship - Cleveland Clinic
Pulmonary / Critical Care Medi
Cleveland, OH USA
2003
Residency - Yale-New Haven Hospital
Internal Medicine
New Haven, CT USA
2000
Internship - Yale-New Haven Hospital
Internal Medicine
New Haven, CT USA
1997
Medical School - MCP Hahnemann University School of Medicine
Philadelphia, PA USA
1996
Undergraduate - University of Scranton
Biology
PA USA
1992

Certifications

  • Internal Medicine- Pulmonary Disease

Specialty Interests

Advanced diagnostic and therapeutic bronchoscopy, lung cancer

Awards & Honors

  • Best Doctors in America, 2007-2008
  • Physician Development Award, AlphaOne Foundation, 2006-2008
  • Finalist, 2004 CHEST Foundation Best Poster in Category Award
  • Clinical Research Award Finalist, American College of Chest Physicians, Chest Foundation, 2002

Additional Training

  • Clinical Research Scholars Program, Case Western Reserve University, Masters in Clinical Research program

Innovations & Patents

First physician in North America to perform electromagnetic navigation bronchoscopy

Memberships

  • American Thoracic Society
  • Fellow, American College of Chest Physicians
  • American Association for Bronchology
  • World Association for Bronchology

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/1/2014, Dr. Gildea has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Gildea received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Covidien plc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Spanish
Cleveland Clinic Mobile Site